A Randomized, Observer-blinded, Parallel-group, Active-control, Phase ½ Trial Of The Safety, Immunogenicity, And Tolerability Of 20 Mg, 60 Mg, And 200 Mg Of Meningococcal Group B Rlp2086 Vaccine In Healthy Children And Adolescents Aged 8 To 14 Years
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010792/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Study to evaluate the safety of an investigational meningitis vaccine and the immune response to it in adolescents
提供机构：
Vivli
创建时间：
2024-11-21
